To determine the relationship between Vav2 and EMP1 in prostate cancer cells, we first confirmed that Vav2 expression levels were similar between LNCaP #2 and #17 cells (Fig. 8a, b). This evidence concerns the gene VAV2 and prostate carcinoma.